Crucially, ZnO demonstrates a strong immunomodulatory capability, promoting T-cell activation and dendritic cell maturation necessary to reverse the 'cold' tumor microenvironment often associated with solid and deep-seated tumors. Overall, ZnO NPs offer revolutionary therapeutic prospects for novel anti-cancer treatments, provided that challenges regarding long-term stability and controlled degradability are addressed in future works for clinical translation.
Conte et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: